ADVERTISEMENT
4 /5 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Natural Products

Genentech and Lodo team to discover natural products

by Lisa Jarvis
May 13, 2018 | APPEARED IN VOLUME 96, ISSUE 20

 

Genentech will work with New York City-based Lodo Therapeutics to mine bacterial genomes for novel natural products. Deal specifics were not disclosed, but Lodo could get up to $969 million as projects progress. Lodo, which was one of C&EN’s 10 Start-ups to Watch in 2016, is based on methods developed by its cofounder, Rockefeller University chemist Sean Brady. His group searches bacterial genomes for gene clusters that encode for unique molecules with specific properties.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment